Friday May 24, 2019 Change 0.48% Price $40.18
Chart period: 2019-02-25 - 2019-05-24
VOLUME
Sell
TREND
Sell
MV LONG
Sell

MV SHORT
Buy

PIVOT
Sell

MACD
Sell

Will GSK stock price go up or down on Tue, 28 May 2019?

Predict

GlaxoSmithKline PLC Forecast and Stock Analysis

Technical GSK stock analysis for Friday May 24, 2019.

Sell candidate since 2019-05-06 Loss -0.86%
Shorts 3.20% ( 2019-04-15 )
Insider % n/a
Institutional % 12.60%
Beta 0.37
ROA 6.95%
Price to book USD 18.06
P/E Ratio 19.41
Next Earnings Date 2019-07-24


GlaxoSmithKline PLC gained 0.48% in the last trading day ( Friday, 24th May 2019 ), rising from $39.99 to $40.18 During day the stock fluctuated 0.60% from a day low at $40.08 to a day high of $40.32. The price has fallen in 5 of the last 10 days , but is still up by 1.64% over the past 2 weeks. Volume fell in the last day by -0.15 million shares, and in total, 1.70 million shares bought and sold for approximately $68.38 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Quick summary:

  • 30 day high of the GSK stock price was $41.16 and low was $39.07.
  • 90 day high was $42.20 and low was $39.07.
  • 52 week high for the GlaxoSmithKline PLC - $42.36 and low - $36.41.

Trend

GlaxoSmithKline PLC lies in the middle of a falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.45% during the next 3 months and, with 90% probability hold a price between $38.12 and $40.26 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. GlaxoSmithKline PLC holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $40.21. On a fall, the stock will find some support from the short-term average at $39.71. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Wednesday May 22, 2019, which indicates further falls until a new bottom pivot has been found.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 45 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

GlaxoSmithKline PLC finds support from accumulated volume at $40.12.

Support: $40.12 Price: $40.18 Resistance: $40.22

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.24 (0.60%) between high and low. For the last week, the stock has had a daily average volatility of 0.94%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

0.94 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Stronger Sell Today GSK ranks #4273 as SELL CANDIDATE #4273 Weaker Sell
GSK $40.18 ($0.19 0.48%)
GSK is up $0.19 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for GSK based on the 1-3 month system that more than doubles the S&P 500.

This report is free today for StockInvest.us readers.

Click here – the GSK analysis is free »

Will GSK stock price go up or down
on Tue, 28 May 2019?

Predict

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank